✦ LIBER ✦

Pilot study of natural human interleukin-2 in patients with chronic hepatitis B: Immunomodulatory and antiviral effects

✍ Scribed by Herbert Tilg; Wolfgang Vogel; Jeanie Tratkiewicz; Walter Ernst Aulitzky; Manfred Herold; Michael Gruber; Dietmar Geissler; Florian Umlauft; Gert Judmaier; Ulrich Schwulera; Alexander Thrun; Christian Huber

Book ID: 118566429
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 635 KB
Volume: 19
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80580-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of recombinant human interle

Pilot study of recombinant human interleukin 2 for chronic type B hepatitis

✍ Shinichi Kakumu; Akihiko Fuji; Kentaro Yoshioka; Hirofumi Tahara; Yoshiyuki Ohta 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Recombinant human interleukin 2 was administered to 10 patients with chronic type B hepatitis as a part of a pilot study to evaluate its antiviral activity. Patients received 1 to 3 x 10' units per day of interleukin 2 for 21 to 28 days, and all completed the treatment schedule. During therapy, seru

Tolerance and Antiviral Effects of High-

Tolerance and Antiviral Effects of High-Dose Interferon-α B/D in Patients with Chronic Hepatitis B

✍ M. C. Rasch; H. Schellekens; C. M. M. Van Dijck; E. B. Haagsma; P. P. Michielsen 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 135 KB

A pilot study of 2 years of interferon t

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis

✍ C. Yurdaydın; H. Bozkaya; H. Karaaslan; F. O. Önder; Ö. E. Erkan; K. Yalçın; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

A phase I/II study of recombinant human

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C

✍ Stefan Zeuzem; Uwe Hopf; Vicente Carreno; Moisés Diago; Mitchell Shiffman; Stefa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

PGI2 COST EFFECTIVENESS AND BUDGET IMPAC

PGI2 COST EFFECTIVENESS AND BUDGET IMPACT OF LAMIVUDINE ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS TYPE B PATIENTS IN TAIWAN

✍ WY Shau; IC Tsai; PA Scuffham; KX Dziekan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Clinical and immunological efficacy of i

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B

✍ Anja Dahmen; Sabine Herzog-Hauff; Wulf O. Böcher; Peter R. Galle; Hanns F. Löhr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine together with daily Interleukin‐2 (IL‐2